The impact of patent activity on idiosyncratic volatility in U.S. pharmaceutical companies.
This study examines the impact of patent activity on the idiosyncratic volatility (IVOL) of U.S. pharmaceutical companies, addressing a critical gap in the literature on the relationship between innovation and firm-specific risk. Using panel data from Thomson Reuters/Refinitiv covering 2,910 firms o...
| Published in: | PLoS ONE |
|---|---|
| Main Authors: | , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Online Access: | https://doi.org/10.1371/journal.pone.0334970 |